Logos may reduce the risk of a heart attack, and detect pioneering research Vaccines and immunization
Obtaining the logic vaccine may reduce the risk of a heart attack or a stroke by up to 20 %, according to the first study of its kind.
Logos is a common condition that affects millions around the world, which causes a painful rash and can lead to serious problems such as deafness, long -term pain and blindness. It is likely to cause serious problems in the older age groups.
Most countries tend to recommend only a vaccine for the elderly or adults with immunodeficiency, but the results indicate that they can have protective and vascular effects in adults up to 18 years.
The results of the study, which is the first global systematic review in the world and definition analysis, shows that JAB is associated with a significant decrease in the risk of cardiovascular events.
The possession of logical impetigo is linked to 18 % of the risk of stroke or heart attack in adults 18 and above. There was a 16 % decrease in the risk of cardiovascular events in adults 50 or larger.
Data will be presented at the end of this week to thousands of cardiologists at the annual meeting of European Society for Heart Diseases In Madrid, the largest heart disease conference in the world.
Dr. Charles Williams, author of the study and global assistant director of GSK, said: “We have looked at the evidence currently available, and we found that in this analysis, vaccination against herpes herpes was linked to a lower risk of cardiovascular events, such as heart attacks or strokes.
“More research studies are now needed to see if this bond can be attributed to the effect of vibrant herpes vaccination.”
The global systematic review was carried out using three databases of scientific literature, and a twin analysis of the 3 random experiments and monitoring studies was carried out to evaluate herpes vaccination on cardiovascular events.
Logical imbalances are usually taken once, usually managed in two doses, several months away.
In total, 19 studies were included in the review. Eight monitoring and one experiment studies, randomly governed, have met the criteria for inclusion to study the effect of JAB on cardiovascular events.
Vaccination is increasingly seen as an effective measure not only against specific infections, but also to prevent cardiovascular disease.
“These results support an increasing group of evidence … which indicates that vaccines reduce the risk of cardiovascular disease,” said Professor Philipo Cray, a professor of cardiology at the Catholic University of Rome, who did not participate in the study.
Professor Brian Williams, chief scientific and medical official at the British Heart Foundation, also welcomed the research, but he said that more research was needed.
He said: “There is a great interest in studies that indicate that the logical impermissibility vaccine may reduce the risk of cardiovascular events, although this analysis is largely dependent on monitoring studies, which cannot show the cause and the result.
“We know that logical images can cause inflammation in the body, and that inflammation is the cause of many heart and blood circulation that can lead to heart attacks and stroke strokes.
“By preventing logical impetigo, vaccination can be preventive. But more research is needed, especially to understand interesting results for young people. More evidence will be needed before recommending the logic vaccine vaccine for a wider age group.”
The results came as NHS England said 300,000 people will be qualified to get the shogy imbalances from next week.
September 1 people are those between the ages of 18 and 49 with a very weak immune system. NHS has previously expanded eligibility to include people over 50 years old with a very weak immune system.